Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment BusinessWire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on JNJ
    ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.
    2:55p ET April 5 '24 PR Newswire

    Rowley Law PLLC is investigating potential securities law violations by Shockwave Medical, Inc. (NASDAQ: SWAV) and its board of directors concerning the proposed acquisition of the company by Johnson & Johnson (NYSE: JNJ). Stockholders will receive $335.00 for each share of Shockwave Medical stock that they hold. The transaction is valued at approximately $13.1 billion and is expected to close by mid-2024.

    If you are a stockholder of Shockwave Medical, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at:http://www.rowleylawpllc.com/investigation/swav/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

    Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.

    Attorney Advertising. Prior results do not guarantee a similar outcome.

    https://c212.net/c/img/favicon.png?sn=NY80967&sd=2024-04-05

    View original content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-shockwave-medical-inc-302109460.html

    SOURCE Rowley Law PLLC

    https://rt.newswire.ca/rt.gif?NewsItemId=NY80967&Transmission_Id=202404051455PR_NEWS_USPR_____NY80967&DateId=20240405

    COMTEX_450387977/1005/2024-04-05T14:55:24

    Kenvue Announces Pricing of Secondary Offering
    7:13p ET May 14 '24 BusinessWire
    Kenvue Announces Launch of Secondary Offering
    6:46a ET May 13 '24 BusinessWire
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:16p ET May 9 '24 PR Newswire Europe
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:15p ET May 9 '24 PR Newswire
    Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Glo...
    4:30p ET May 8 '24 BusinessWire
    Shockwave Medical Reports First Quarter 2024 Financial Results
    4:05p ET May 6 '24 GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:22p ET May 6 '24 GlobeNewswire
    Johnson & Johnson to Participate in the 2024 RBC Capital Markets Glob...
    6:06p ET April 8 '24 BusinessWire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:48p ET April 8 '24 GlobeNewswire
    CARVYKTI(R) is the First and Only BCMA-Targeted Treatment Approved by...
    11:22p ET April 5 '24 PR Newswire

    Market data provided by News provided by